ANAna Nava-Cabrera

Ana Nava-Cabrera

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Nava-Cabrera has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Differential Expression of microRNAs in Obese Mexican Children: Links to Insulin Resistance and Dyslipidemia

    by Alejandra Contreras-Ramos, Guadalupe Díaz-Rosas, Miguel Cruz, Ana Nava-Cabrera, Miguel Vazquez-Moreno, Omar Gómez-Acuña, Ana María Guerrero-Ortiz, Carmen Domínguez-Hernández, Aleyda Pérez-Herrera, Rosalinda Jiménez-Aguilar, et al.

    To analyze, in an analytical cross-sectional observational study, the relationship between the plasma microRNA (miRNA) expression profile in children living with obesity and their metabolic health status. Based on body mass index percentiles (BMIp), the children were grouped into a control group (C) or an obesity group (Ob). Glucose, insulin, and low- and high-density lipoproteins (LDLs and HDLs, respectively), triacylglycerols (TG), and total cholesterol (TC) were measured. RNA from plasma was used for miRNA sequencing analysis (NextSeq 2000 platform). Differential miRNA expression was determined using counts obtained from the reference genome. Fifty controls (BMIp: 50.4 ± 23) and fifty children with obesity (BMIp: 97.54 ± 1.46) were included. The obese group presented hyperinsulinemia and insulin resistance. Sequencing revealed nine underexpressed and six overexpressed miRNAs in the obese group. In silico analysis suggested that these miRNAs may participate in regulating insulin secretion, protein synthesis, apoptosis, and the glycolytic pathway in pancreatic β-cells. Childhood obesity was associated with altered circulating levels of microRNAs linked to glucose metabolism, insulin resistance (IR) and β-cell survival. Reduced plasma levels of miR-126-3p, let-7a-5p, and miR-16-5p showed a high predictive value for hypertriglyceridemia and insulin resistance, indicating their potential relevance as early biomarkers or therapeutic targets in pediatric metabolic dysfunction.

  • Open Access

    Altered Expression of the MEG3, FTO, ATF4, and Lipogenic Genes in PBMCs from Children with Obesity and Its Associations with Added Sugar Intake

    by Adrián Hernández-Díazcouder, Pablo J. Paz-González, Maryori Valdez-Garcia, Claudia I. Ramírez-Silva, Karol Iliana Avila-Soto, Araceli Pérez-Bautista, Miguel Vazquez-Moreno, Ana Nava-Cabrera, Rodrigo Romero-Nava, Fengyang Huang, et al.

    Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders at earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipogenic genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study 71 children within the age range of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN, and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was associated with the expression of SREBP1, FASN, ACACA, FTO, and ATF4. In insulin-resistant (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3, FTO, and ATF4 expression was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipogenic gene expression.


  • Association of serum total antioxidant capacity and uric acid with obesity and cardiometabolic traits in Mexican children

    by Ana Nava-Cabrera, Armando Ramírez-Cruz, Araceli Pérez-Bautista, Alan Canul-Ayil, Gloria Chi-Díaz, Elena Flores-Guillén, Miguel Vazquez-Moreno, Miguel Cruz

    Background/objectives Serum total antioxidant capacity (sTAC) and uric acid (SUA) levels have been related to oxidative stress in metabolic diseases. Nevertheless, the evidence in epidemiological studies is still scarce and inconsistent. We aimed to evaluate the association between sTAC, SUA, obesity, and cardiometabolic traits in Mexican children. Subjects/methods This cross-sectional study analyzed anthropometric data, blood pressure, cardiometabolic traits, and SUA levels of 248 children with normal weight (NW) and 255 with obesity (OB). sTAC was measured with the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method. Results sTAC was directly related to SUA (β = 0.905 ± 0.358, p = 0.012). Obesity was positively associated with sTAC (β = 0.075 ± 0.020, p < 0.001) and SUA (β = 0.706 ± 0.129, p < 0.001). sTAC was negatively associated with diastolic blood pressure (β = -8.458 ± 3.758, p = 0.026) in NW children and positively associated with insulin (β = 9.511 ± 3.107, p = 0.002) and the homeostatic model assessment of insulin resistance (β = 2.065 ± 0.680, p = 0.003) in OB children. SUA showed negative associations with total cholesterol (β = -4.062 ± 1.340, p = 0.003) and low-density lipoprotein cholesterol (β = -2.470 ± 1.190, p = 0.039) in NW children and high-density lipoprotein cholesterol (β = -1.306 ± 0.409, p < 0.01) in OB children. Conclusion sTAC and SUA are positively associated and are increased in obesity. According to weight status, sTAC and SUA are associated with blood pressure, insulin resistance markers, and lipid profile.


  • Open Access

    Genetic Variants in Antioxidant Genes Modulate the Relationships Among Obesity-Related Oxidative Stress Markers in Mexican Children

    by Ana Nava-Cabrera, Armando Ramírez-Cruz, Jaime Gómez-Zamudio, Araceli Pérez-Bautista, Linda Esther Ruiz-Queb, Miguel Vazquez-Moreno, Miguel Cruz

    Single-nucleotide polymorphisms (SNPs) in antioxidant genes could influence redox regulation from early life. We aimed to assess the direct and modulatory effects of SNPs in antioxidant genes (SOD2 rs4880, GPX1 rs1050450, GPX7 rs835337, CAT rs1001179) on the relationships among obesity-related oxidative stress markers in Mexican children. Anthropometric data of 2946 unrelated children were analyzed in this cross-sectional study. SNPs were genotyped using TaqMan assay. Serum total antioxidant capacity (sTAC) and oxidative stress markers (thiobarbituric acid reactive substances [TBARS, as lipid peroxidation], and protein carbonyl [PC]) were assessed. Although no SNPs were associated with obesity (p ≥ 0.125), both sTAC (p = 0.001) and TBARS (p = 0.015) were positively associated with it. A negative relationship was also observed between sTAC and TBARS (p < 0.001). SOD2 rs4880 was negatively associated with TBARS, while GPX1 rs1050450 was inversely associated with both TBARS and PC levels (p ≤ 0.036). The inverse association between sTAC and TBARS remained significant only in non-carriers of SOD2 rs4880 (p = 0.003) and GPX1 rs1050450 (p = 0.002). Our data evidence that sTAC and TBARS are associated with obesity, showing a negative relationship in Mexican children who are non-carriers of SOD2 rs4880 and GPX1 rs1050450.


  • Open Access

    Altered Expression of the MEG3–FTO–ATF4 Axis and Lipid Metabolism Genes in PBMCs from Children with Obesity and Its Associations and Added Sugar Intake

    by Adrián Hernández-Díazcouder, Pablo Javier Paz González, Maryori Valdez-Garcia, Ci Ramírez-Silva, Karol Iliana Avila-Soto, Araceli Pérez-Bautista, Miguel Vazquez-Moreno, Ana Nava-Cabrera, Rodrigo Romero-Nava, Fengyang Huang, et al.

    Background: Obesity and its complications have increased in both adults and children, with pediatric populations developing metabolic disorders earlier ages. Long non-coding RNAs, particularly MEG3, are involved in obesity through regulation of lipid metabolism genes including ATF4, FTO, SREBP1, FASN, and ACACA. However, data on MEG3 expression in pediatric obesity are limited. This study evaluated MEG3, FTO, and ATF4 expression in PBMCs from children with obesity and their associations with added sugar intake and lipid metabolism genes. Methods: In this cross-sectional study a total of 71 children aged of 6 to 12 years were included (28 normal weight and 43 with obesity). Anthropometrical and clinical parameters and dietary added sugar consumption were analyzed. Real-time PCR was performed to assess MEG3, FTO, ATF4, SREBP1, FASN and ACACA gene expression in peripheral blood mononuclear cells. Results: The expression of MEG3, ATF4, FTO, SREBP1, FASN, and ACACA was decreased in children with obesity. MEG3 and FTO showed sex-dependent expression in children without obesity, while additional sex-related differences were observed for SREBP1, FASN, ACACA, FTO, and MEG3 in children with obesity. MEG3 was correlated with increased levels of ATF4 and SREBP1, and moderately with FTO and FASN. In insulin resistance (IR) children, MEG3, ATF4, FTO, ACACA, and SREBP1 were reduced, while FASN was increased. Added sugar intake negatively correlated with FTO, SREBP1, and ACACA. Conclusions: The MEG3–FTO–ATF4 axis was altered in children with obesity, showing sex- and IR-related differences. Added sugar intake correlated negatively with lipid metabolism gene expression.